Webinar: The Future of Medicated Chewing Gum
Sponsored by: Cafosa Gum SAU
Focused on:
Date: 26th April
Days old: 4668
Time: 3PM London / 10AM New York
Health in Gum, a new drug delivery system to produce a medicated chewing gum
Are you planning to use innovative oral drug delivery systems? Do you want to produce a medicated chewing gum with no investment in equipment? In this webinar session we will explain and investigate easy options on how to obtain a medicated chewing gum.
'Health in Gum' is a powder gum specially designed to produce an easy to create medicated chewing gum. This solution helps to provide a mix of Gum Base, Softeners and Polyois that enables users to innovate into oral drug delivery systems. The process of adding your API and the ability to compress it into tablet equipment to obtain a compacted product is one of the many advantages. Other advantages are as follows:
- Attractive and pleasant format that improves compliance.
- Fast onset of action. Search for immediate effect.
- Patient’s active control over treatment.
- A balanced and controlled intake.
- Provides systemic and local effect.
- Reduces exposure to gastrointestinal side effects caused by APIs.
- For either therapeutic or functional use.
Recent successful examples of chewing gum acting as a oral drug delivery system are:
Cold Relief Chewing Gum
In this case we entered into a new application for medicated gum, with Ceritizine as the active ingredient used in the formulation for the first time. The study demonstrated the correct uniformity of content and release of Cetirizine after 15 minutes of chewing and thus the effectiveness of the drug delivery system also for cough and cold products.
Energy Chewing Gum
Caffeine is already being used as an attractive ingredient to be administered as a chewing gum. It increases alertness and provides energy to drivers, sportsmen, soldiers etc. Here, the critical point was to evaluate the amount of caffeine released from the gum by chewing. Results in research with ‘Health in Gum’ caffeinated chewing gums demonstrated total release of the caffeine by chewing during 15 minutes, highlighting the convenience of this innovative delivery system.
Presented by
Mr. Marc Ribé,,
Project Manager, Pharma B.U.
Graduate in Biology, Medical branch. Barcelona
MBA Interuniversitari Fundació Boch i Gimpera
8 year experience in Marketing & Sales of Excipients and Intermediates for the Spanish and Portuguese Pharma markets with Quimidroga.
Currently developing a worldwide introduction of Health in Gum for Cafosa Gum SAU.
Projects:
Assessment on excipients and formulation of solid and semisolid dosage forms, focused in the Spanish pharmaceutical market.
Special excipients for oral drug delivery systems (ODTs and Controlled release)
Mr. Javier Belmar,,
Gum Technology Advisor
MSc Chemistry
Chemical Engineer at Institute Quimic de Sarria
Master on Environmental Management
10 year experience as Gum Technology Advisor at CAFOSA, responsible of the CAFOSA’s Worldwide Technical Services since 2005.
Main developer of AiG/HiG the project for the past 5 years.
Manager of the Sensory Analytical panel since 2007
Lecturer on ZDS confectionery school for gum seminar since 2009
Projects
Exploration of new HiG formulations and ingredients
Industrial scale-up and optimization
Development of methods for gum characterization
Key Learning Objectives
- Inherent benefits of Chewing Gum
- Patient’s active control over treatment with a balanced and controlled intake
- In-depth analysis of Recent Case Studies - Cold Relief Chewing Gum & Energy Chewing Gum
- Technical details of the product versus commercial opportunities for Pharmaceutical companies
Audience
- CEO/President/Chairman/Executive Director
- Heads of R&D
- Heads of Formulation
- Heads of Drug Delivery
- Heads of Product Development
- Heads of Business Development
- Heads of Product Development
- Heads of Innovation
- Managing Directors
- Principle Scientists
- Researchers